EXACT Operating Income from 2010 to 2024

EXAS Stock

USD 55.14 2.23 4.21%

EXACT Sciences Operating Income yearly trend continues to be comparatively stable with very little volatility. Operating Income is likely to outpace its year average in 2024. Operating Income is earnings before interest and taxes (EBIT), representing the amount of profit EXACT Sciences generates from its operations. View All Fundamentals

Operating Income

First Reported

2000-03-31

Previous Quarter

-21.9 M

Current Value

-29.1 M

Quarterly Volatility

66.4 M

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Check EXACT Sciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among EXACT Sciences' main balance sheet or income statement drivers, such as Interest Expense of 25.6 M, Other Operating Expenses of 2.9 B or Research Development of 447.2 M, as well as many indicators such as Price To Sales Ratio of 5.06, Dividend Yield of 0.0 or PTB Ratio of 4.47. EXACT financial statements analysis is a perfect complement when working with EXACT Sciences Valuation or Volatility modules.

Check out the analysis of EXACT Sciences Correlation against competitors.

For more information on how to buy EXACT Stock please use our How to Invest in EXACT Sciences guide.

Latest EXACT Sciences' Operating Income Growth Pattern

Below is the plot of the Operating Income of EXACT Sciences over the last few years. Operating Income is the amount of profit realized from EXACT Sciences operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of EXACT Sciences is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. It is earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations. EXACT Sciences' Operating Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in EXACT Sciences' overall financial position and show how it may be relating to other accounts over time.

Operating Income

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Operating Income

Timeline

EXACT Operating Income Regression Statistics

	Arithmetic Mean	(230,871,293)
	Coefficient Of Variation	(103.26)
	Mean Deviation	170,887,977
	Median	(159,471,000)
	Standard Deviation	238,389,431
	Sample Variance	56829.5T
	Range	831.4M
	R-Value	(0.66)
	Mean Square Error	34754.6T
	R-Squared	0.43
	Significance	0.01
	Slope	(35,040,964)
	Total Sum of Squares	795613.3T

EXACT Operating Income History

	2024	-204.3 M
	2023	-215 M
	2022	-577.5 M
	2021	-835.5 M
	2020	-558.4 M
	2019	-233.8 M
	2018	-159.5 M

Other Fundumenentals of EXACT Sciences

Non Operating Income Net Other

EXACT Sciences Operating Income component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Total Liab	Total Current Assets	Retained Earnings	Accounts Payable	Common Stock	Intangible Assets	Property Plant Equipment	Good Will	Short Term Investments	Current Deferred Revenue	Long Term Debt	Net Tangible Assets	Long Term Debt Total	Capital Surpluse	Accumulated Depreciation	Short Term Debt	Net Receivables	Short Long Term Debt	Net Invested Capital	Long Term Investments	Net Working Capital	Capital Stock
Total Assets		0.99	0.9	0.99	0.79	-0.97	0.97	0.88	0.98	0.99	0.99	0.29	0.59	0.99	-0.02	0.98	0.99	-0.72	0.45	0.92	0.53	0.98	-0.55	0.53	0.99
Total Stockholder Equity	0.99		0.86	0.97	0.8	-0.94	0.94	0.89	0.96	0.98	0.97	0.27	0.64	0.96	-0.04	0.97	0.98	-0.75	0.49	0.94	0.56	0.98	-0.51	0.54	0.98
Net Debt	0.9	0.86		0.93	0.52	-0.92	0.95	0.77	0.95	0.93	0.94	0.3	0.39	0.94	-0.1	0.86	0.91	-0.58	0.04	0.71	0.14	0.87	-0.57	0.23	0.91
Total Liab	0.99	0.97	0.93		0.77	-0.98	0.98	0.86	0.97	0.99	0.98	0.31	0.54	1.0	0.0	0.98	0.99	-0.68	0.4	0.88	0.49	0.97	-0.59	0.52	0.99
Total Current Assets	0.79	0.8	0.52	0.77		-0.74	0.72	0.79	0.65	0.75	0.68	0.57	0.69	0.76	0.15	0.84	0.76	-0.77	0.77	0.87	0.81	0.79	-0.31	0.92	0.72
Retained Earnings	-0.97	-0.94	-0.92	-0.98	-0.74		-0.98	-0.9	-0.94	-0.96	-0.96	-0.29	-0.42	-0.98	-0.14	-0.96	-0.98	0.72	-0.38	-0.84	-0.45	-0.93	0.62	-0.47	-0.97
Accounts Payable	0.97	0.94	0.95	0.98	0.72	-0.98		0.87	0.96	0.98	0.96	0.34	0.45	0.99	0.07	0.96	0.98	-0.7	0.3	0.82	0.38	0.93	-0.63	0.46	0.96
Common Stock	0.88	0.89	0.77	0.86	0.79	-0.9	0.87		0.83	0.89	0.84	0.44	0.55	0.86	0.13	0.86	0.89	-0.88	0.4	0.82	0.45	0.84	-0.49	0.5	0.84
Intangible Assets	0.98	0.96	0.95	0.97	0.65	-0.94	0.96	0.83		0.98	1.0	0.2	0.54	0.97	-0.12	0.93	0.97	-0.64	0.28	0.86	0.37	0.96	-0.55	0.35	0.98
Property Plant Equipment	0.99	0.98	0.93	0.99	0.75	-0.96	0.98	0.89	0.98		0.98	0.31	0.57	0.99	-0.02	0.97	0.99	-0.73	0.36	0.88	0.43	0.96	-0.6	0.48	0.97
Good Will	0.99	0.97	0.94	0.98	0.68	-0.96	0.96	0.84	1.0	0.98		0.18	0.51	0.98	-0.06	0.96	0.98	-0.64	0.34	0.87	0.43	0.96	-0.59	0.4	0.99
Short Term Investments	0.29	0.27	0.3	0.31	0.57	-0.29	0.34	0.44	0.2	0.31	0.18		0.52	0.32	-0.11	0.29	0.24	-0.61	0.06	0.32	0.13	0.29	0.13	0.55	0.17
Current Deferred Revenue	0.59	0.64	0.39	0.54	0.69	-0.42	0.45	0.55	0.54	0.57	0.51	0.52		0.52	-0.57	0.55	0.5	-0.6	0.42	0.73	0.48	0.62	0.0	0.58	0.51
Long Term Debt	0.99	0.96	0.94	1.0	0.76	-0.98	0.99	0.86	0.97	0.99	0.98	0.32	0.52		0.02	0.98	0.99	-0.68	0.38	0.87	0.46	0.96	-0.6	0.52	0.98
Net Tangible Assets	-0.02	-0.04	-0.1	0.0	0.15	-0.14	0.07	0.13	-0.12	-0.02	-0.06	-0.11	-0.57	0.02		0.09	0.08	-0.12	0.31	-0.08	0.24	-0.06	-0.3	0.2	0.0
Long Term Debt Total	0.98	0.97	0.86	0.98	0.84	-0.96	0.96	0.86	0.93	0.97	0.96	0.29	0.55	0.98	0.09		0.98	-0.68	0.55	0.91	0.61	0.96	-0.59	0.63	0.97
Capital Surpluse	0.99	0.98	0.91	0.99	0.76	-0.98	0.98	0.89	0.97	0.99	0.98	0.24	0.5	0.99	0.08	0.98		-0.71	0.43	0.88	0.5	0.96	-0.64	0.5	0.99
Accumulated Depreciation	-0.72	-0.75	-0.58	-0.68	-0.77	0.72	-0.7	-0.88	-0.64	-0.73	-0.64	-0.61	-0.6	-0.68	-0.12	-0.68	-0.71		-0.37	-0.74	-0.42	-0.7	0.23	-0.53	-0.64
Short Term Debt	0.45	0.49	0.04	0.4	0.77	-0.38	0.3	0.4	0.28	0.36	0.34	0.06	0.42	0.38	0.31	0.55	0.43	-0.37		0.66	0.99	0.5	-0.1	0.81	0.43
Net Receivables	0.92	0.94	0.71	0.88	0.87	-0.84	0.82	0.82	0.86	0.88	0.87	0.32	0.73	0.87	-0.08	0.91	0.88	-0.74	0.66		0.72	0.96	-0.28	0.65	0.9
Short Long Term Debt	0.53	0.56	0.14	0.49	0.81	-0.45	0.38	0.45	0.37	0.43	0.43	0.13	0.48	0.46	0.24	0.61	0.5	-0.42	0.99	0.72		0.57	-0.1	0.84	0.51
Net Invested Capital	0.98	0.98	0.87	0.97	0.79	-0.93	0.93	0.84	0.96	0.96	0.96	0.29	0.62	0.96	-0.06	0.96	0.96	-0.7	0.5	0.96	0.57		-0.41	0.54	0.98
Long Term Investments	-0.55	-0.51	-0.57	-0.59	-0.31	0.62	-0.63	-0.49	-0.55	-0.6	-0.59	0.13	0.0	-0.6	-0.3	-0.59	-0.64	0.23	-0.1	-0.28	-0.1	-0.41		-0.2	-0.56
Net Working Capital	0.53	0.54	0.23	0.52	0.92	-0.47	0.46	0.5	0.35	0.48	0.4	0.55	0.58	0.52	0.2	0.63	0.5	-0.53	0.81	0.65	0.84	0.54	-0.2		0.45
Capital Stock	0.99	0.98	0.91	0.99	0.72	-0.97	0.96	0.84	0.98	0.97	0.99	0.17	0.51	0.98	0.0	0.97	0.99	-0.64	0.43	0.9	0.51	0.98	-0.56	0.45

Click cells to compare fundamentals

About EXACT Sciences Financial Statements

EXACT Sciences shareholders use historical fundamental indicators, such as Operating Income, to determine how well the company is positioned to perform in the future. Although EXACT Sciences investors may analyze each financial statement separately, they are all interrelated. The changes in EXACT Sciences' assets and liabilities, for example, are also reflected in the revenues and expenses on on EXACT Sciences' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.

	Last Reported	Projected for Next Year
Operating Income	-215 M	-204.3 M
Non Operating Income Net Other	-22.3 M	-21.2 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for EXACT Stock Analysis

When running EXACT Sciences' price analysis, check to measure EXACT Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy EXACT Sciences is operating at the current time. Most of EXACT Sciences' value examination focuses on studying past and present price action to predict the probability of EXACT Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move EXACT Sciences' price. Additionally, you may evaluate how the addition of EXACT Sciences to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

EXACT Operating Income from 2010 to 2024

Latest EXACT Sciences' Operating Income Growth Pattern

EXACT Operating Income Regression Statistics

EXACT Operating Income History

Other Fundumenentals of EXACT Sciences

EXACT Sciences Operating Income component correlations

About EXACT Sciences Financial Statements

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for EXACT Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY